Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you.
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities.
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless.
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest.
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions.
- Other sectors: From media to academia, we work with sectors as diverse as our data.
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on:
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge.
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them.
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Tedizolid Phosphate in Wounds
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tedizolid Phosphate in Wounds report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tedizolid Phosphate in WoundsDrug Details: Tedizolid phosphate (TR-701, DA-7218, Sivextro) is a phosphate...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Tedizolid Phosphate in Cellulitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tedizolid Phosphate in Cellulitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tedizolid Phosphate in CellulitisDrug Details: Tedizolid phosphate (TR-701, DA-7218, Sivextro) is a phosphate...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Crizanlizumab in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crizanlizumab in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Crizanlizumab in Chronic Kidney Disease (Chronic Renal Failure)Drug Details:Crizanlizumab-TMCA...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Interstitial Cystitis (Painful...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Essential Tremor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Essential Tremor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Essential Tremor Drug Details: Onabotulinumtoxin A (Botox /...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - AT-101 in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-101 in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-101 in Laryngeal Cancer Drug Details: AT-101 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Tisagenlecleucel in Primary CNS Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tisagenlecleucel in Primary CNS Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tisagenlecleucel in Primary CNS LymphomaDrug Details:Tisagenlecleucel (Kymriah) is a CD19-directed genetically modified...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Melphalan Hydrochloride in Ocular Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Melphalan Hydrochloride in Ocular Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Melphalan Hydrochloride in Ocular Melanoma Drug Details: Melphalan hydrochloride (Hepzato, Hepzato...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Atrasentan Hydrochloride in Focal Segmental Glomerulosclerosis (FSGS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Atrasentan Hydrochloride in Focal Segmental Glomerulosclerosis (FSGS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atrasentan Hydrochloride in Focal Segmental Glomerulosclerosis (FSGS) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Vorinostat in Head And Neck Cancer Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vorinostat in Head And Neck Cancer Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vorinostat in Head And Neck Cancer Squamous...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.